Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy:
Gespeichert in:
| Körperschaft: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Lyon, France
International Agency for Research on Cancer
2007
|
| Schriftenreihe: | IARC monographs on the evaluation of carcinogenic risks to humans
v. 91 |
| Schlagworte: | |
| Beschreibung: | At head of title: World Health Organization, International Agency for Research on Cancer. - "This publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 7-14 June 2005." Includes bibliographical references and cumulative index |
| Beschreibung: | ix, 528 p. |
| ISBN: | 9789283212911 9283212916 |
Internformat
MARC
| LEADER | 00000nmm a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV044130973 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 170217s2007 |||| o||u| ||||||eng d | ||
| 020 | |a 9789283212911 |9 978-92-832-1291-1 | ||
| 020 | |a 9283212916 |9 92-832-1291-6 | ||
| 035 | |a (ZDB-30-PAD)EBC367976 | ||
| 035 | |a (ZDB-89-EBL)EBL367976 | ||
| 035 | |a (OCoLC)549589240 | ||
| 035 | |a (DE-599)BVBBV044130973 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 082 | 0 | |a 616.994071 |2 22 | |
| 110 | 2 | |a IARC Working Group on the Evaluation of Carcinogenic Risks to Humans <2005, Lyon, France> |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy |
| 264 | 1 | |a Lyon, France |b International Agency for Research on Cancer |c 2007 | |
| 300 | |a ix, 528 p. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a IARC monographs on the evaluation of carcinogenic risks to humans |v v. 91 | |
| 500 | |a At head of title: World Health Organization, International Agency for Research on Cancer. - "This publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 7-14 June 2005." | ||
| 500 | |a Includes bibliographical references and cumulative index | ||
| 650 | 4 | |a Frau | |
| 650 | 4 | |a Progestational hormones |x Carcinogenicity | |
| 650 | 4 | |a Progestational hormones |x Side effects | |
| 650 | 4 | |a Catechol estrogens |x Carcinogenicity | |
| 650 | 4 | |a Estrogen |x Carcinogenicity | |
| 650 | 4 | |a Catechol estrogens |x Side effects | |
| 650 | 4 | |a Estrogen |x Side effects | |
| 650 | 4 | |a Contraception |x Complications | |
| 650 | 4 | |a Menopause |x Hormone therapy |x Complications | |
| 650 | 4 | |a Chemical carcinogenesis | |
| 650 | 4 | |a Cancer |x Risk factors | |
| 650 | 4 | |a Women |x Diseases |x Risk factors | |
| 650 | 4 | |a Oral contraceptives |x Carcinogenicity | |
| 710 | 2 | |a World Health Organization |e Sonstige |4 oth | |
| 710 | 2 | |a International Agency for Research on Cancer |e Sonstige |4 oth | |
| 912 | |a ZDB-30-PAD | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-029537818 | ||
Datensatz im Suchindex
| _version_ | 1804177219628564480 |
|---|---|
| any_adam_object | |
| author_corporate | IARC Working Group on the Evaluation of Carcinogenic Risks to Humans <2005, Lyon, France> |
| author_corporate_role | aut |
| author_facet | IARC Working Group on the Evaluation of Carcinogenic Risks to Humans <2005, Lyon, France> |
| author_sort | IARC Working Group on the Evaluation of Carcinogenic Risks to Humans <2005, Lyon, France> |
| building | Verbundindex |
| bvnumber | BV044130973 |
| collection | ZDB-30-PAD |
| ctrlnum | (ZDB-30-PAD)EBC367976 (ZDB-89-EBL)EBL367976 (OCoLC)549589240 (DE-599)BVBBV044130973 |
| dewey-full | 616.994071 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.994071 |
| dewey-search | 616.994071 |
| dewey-sort | 3616.994071 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02182nmm a2200517zcb4500</leader><controlfield tag="001">BV044130973</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">170217s2007 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9789283212911</subfield><subfield code="9">978-92-832-1291-1</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9283212916</subfield><subfield code="9">92-832-1291-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-30-PAD)EBC367976</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-89-EBL)EBL367976</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)549589240</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV044130973</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.994071</subfield><subfield code="2">22</subfield></datafield><datafield tag="110" ind1="2" ind2=" "><subfield code="a">IARC Working Group on the Evaluation of Carcinogenic Risks to Humans <2005, Lyon, France></subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Lyon, France</subfield><subfield code="b">International Agency for Research on Cancer</subfield><subfield code="c">2007</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">ix, 528 p.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">IARC monographs on the evaluation of carcinogenic risks to humans</subfield><subfield code="v">v. 91</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">At head of title: World Health Organization, International Agency for Research on Cancer. - "This publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 7-14 June 2005."</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and cumulative index</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Frau</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Progestational hormones</subfield><subfield code="x">Carcinogenicity</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Progestational hormones</subfield><subfield code="x">Side effects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Catechol estrogens</subfield><subfield code="x">Carcinogenicity</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Estrogen</subfield><subfield code="x">Carcinogenicity</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Catechol estrogens</subfield><subfield code="x">Side effects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Estrogen</subfield><subfield code="x">Side effects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Contraception</subfield><subfield code="x">Complications</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Menopause</subfield><subfield code="x">Hormone therapy</subfield><subfield code="x">Complications</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Chemical carcinogenesis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer</subfield><subfield code="x">Risk factors</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Women</subfield><subfield code="x">Diseases</subfield><subfield code="x">Risk factors</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oral contraceptives</subfield><subfield code="x">Carcinogenicity</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">World Health Organization</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">International Agency for Research on Cancer</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-30-PAD</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029537818</subfield></datafield></record></collection> |
| id | DE-604.BV044130973 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:44:36Z |
| institution | BVB |
| isbn | 9789283212911 9283212916 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029537818 |
| oclc_num | 549589240 |
| open_access_boolean | |
| physical | ix, 528 p. |
| psigel | ZDB-30-PAD |
| publishDate | 2007 |
| publishDateSearch | 2007 |
| publishDateSort | 2007 |
| publisher | International Agency for Research on Cancer |
| record_format | marc |
| series2 | IARC monographs on the evaluation of carcinogenic risks to humans |
| spelling | IARC Working Group on the Evaluation of Carcinogenic Risks to Humans <2005, Lyon, France> Verfasser aut Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy Lyon, France International Agency for Research on Cancer 2007 ix, 528 p. txt rdacontent c rdamedia cr rdacarrier IARC monographs on the evaluation of carcinogenic risks to humans v. 91 At head of title: World Health Organization, International Agency for Research on Cancer. - "This publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 7-14 June 2005." Includes bibliographical references and cumulative index Frau Progestational hormones Carcinogenicity Progestational hormones Side effects Catechol estrogens Carcinogenicity Estrogen Carcinogenicity Catechol estrogens Side effects Estrogen Side effects Contraception Complications Menopause Hormone therapy Complications Chemical carcinogenesis Cancer Risk factors Women Diseases Risk factors Oral contraceptives Carcinogenicity World Health Organization Sonstige oth International Agency for Research on Cancer Sonstige oth |
| spellingShingle | Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy Frau Progestational hormones Carcinogenicity Progestational hormones Side effects Catechol estrogens Carcinogenicity Estrogen Carcinogenicity Catechol estrogens Side effects Estrogen Side effects Contraception Complications Menopause Hormone therapy Complications Chemical carcinogenesis Cancer Risk factors Women Diseases Risk factors Oral contraceptives Carcinogenicity |
| title | Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy |
| title_auth | Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy |
| title_exact_search | Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy |
| title_full | Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy |
| title_fullStr | Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy |
| title_full_unstemmed | Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy |
| title_short | Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy |
| title_sort | combined estrogen progestogen contraceptives and combined estrogen progestogen menopausal therapy |
| topic | Frau Progestational hormones Carcinogenicity Progestational hormones Side effects Catechol estrogens Carcinogenicity Estrogen Carcinogenicity Catechol estrogens Side effects Estrogen Side effects Contraception Complications Menopause Hormone therapy Complications Chemical carcinogenesis Cancer Risk factors Women Diseases Risk factors Oral contraceptives Carcinogenicity |
| topic_facet | Frau Progestational hormones Carcinogenicity Progestational hormones Side effects Catechol estrogens Carcinogenicity Estrogen Carcinogenicity Catechol estrogens Side effects Estrogen Side effects Contraception Complications Menopause Hormone therapy Complications Chemical carcinogenesis Cancer Risk factors Women Diseases Risk factors Oral contraceptives Carcinogenicity |
| work_keys_str_mv | AT iarcworkinggroupontheevaluationofcarcinogenicriskstohumans2005lyonfrance combinedestrogenprogestogencontraceptivesandcombinedestrogenprogestogenmenopausaltherapy AT worldhealthorganization combinedestrogenprogestogencontraceptivesandcombinedestrogenprogestogenmenopausaltherapy AT internationalagencyforresearchoncancer combinedestrogenprogestogencontraceptivesandcombinedestrogenprogestogenmenopausaltherapy |